Veracyte Inc (VCYT)
35.02
+0.71
(+2.07%)
USD |
NASDAQ |
Nov 04, 16:00
35.70
+0.68
(+1.94%)
After-Hours: 06:34
Veracyte Market Cap: 2.690B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.690B |
| November 01, 2024 | 2.635B |
| October 31, 2024 | 2.592B |
| October 30, 2024 | 2.688B |
| October 29, 2024 | 2.641B |
| October 28, 2024 | 2.621B |
| October 25, 2024 | 2.537B |
| October 24, 2024 | 2.518B |
| October 23, 2024 | 2.493B |
| October 22, 2024 | 2.504B |
| October 21, 2024 | 2.544B |
| October 18, 2024 | 2.645B |
| October 17, 2024 | 2.635B |
| October 16, 2024 | 2.667B |
| October 15, 2024 | 2.617B |
| October 14, 2024 | 2.606B |
| October 11, 2024 | 2.613B |
| October 10, 2024 | 2.479B |
| October 09, 2024 | 2.452B |
| October 08, 2024 | 2.572B |
| October 07, 2024 | 2.602B |
| October 04, 2024 | 2.523B |
| October 03, 2024 | 2.532B |
| October 02, 2024 | 2.596B |
| October 01, 2024 | 2.545B |
| Date | Value |
|---|---|
| September 30, 2024 | 2.615B |
| September 27, 2024 | 2.594B |
| September 26, 2024 | 2.574B |
| September 25, 2024 | 2.562B |
| September 24, 2024 | 2.591B |
| September 23, 2024 | 2.632B |
| September 20, 2024 | 2.675B |
| September 19, 2024 | 2.708B |
| September 18, 2024 | 2.593B |
| September 17, 2024 | 2.636B |
| September 16, 2024 | 2.583B |
| September 13, 2024 | 2.529B |
| September 12, 2024 | 2.337B |
| September 11, 2024 | 2.329B |
| September 10, 2024 | 2.284B |
| September 09, 2024 | 2.234B |
| September 06, 2024 | 2.195B |
| September 05, 2024 | 2.287B |
| September 04, 2024 | 2.270B |
| September 03, 2024 | 2.327B |
| August 30, 2024 | 2.423B |
| August 29, 2024 | 2.453B |
| August 28, 2024 | 2.429B |
| August 27, 2024 | 2.458B |
| August 26, 2024 | 2.483B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
802.29M
Minimum
Mar 18 2020
5.432B
Maximum
Feb 09 2021
2.047B
Average
1.851B
Median
Market Cap Benchmarks
| Fonar Corp | 93.93M |
| XWELL Inc | 9.173M |
| ProPhase Labs Inc | 41.78M |
| Applied DNA Sciences Inc | 1.885M |
| OncoCyte Corp | 48.82M |
Market Cap Related Metrics
| PS Ratio | 6.526 |
| PEG Ratio | -0.5336 |
| Price to Book Value | 2.375 |
| Price to Free Cash Flow | 64.98 |
| Price | 35.02 |
| Earnings Yield | -2.14% |
| PEGY Ratio | -0.5336 |
| Operating PE Ratio | 1278.23 |
| Normalized PE Ratio | 246.89 |